Complexity of design in early phase respiratory clinical trials; evaluating impact of primary endpoints and sponsor size

Asthma and COPD represent most of the clinical trials in the respiratory area. The Primary Endpoint (PE) defines how trials are conducted. We hypothesised that small and mid-sized pharmaceutical companies may be innovative in the selection of their trial endpoints, to be time- and cost-effective. To...

Descripción completa

Detalles Bibliográficos
Autores principales: Marco-Ariño, Nicolas, Jauhiainen, Alexandra, Betts, Joanne, Da Silva, Carla A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8181183/
https://www.ncbi.nlm.nih.gov/pubmed/34136720
http://dx.doi.org/10.1016/j.conctc.2021.100793

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8181183/
https://www.ncbi.nlm.nih.gov/pubmed/34136720
http://dx.doi.org/10.1016/j.conctc.2021.100793

Ejemplares similares